Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Jeremy J Rose
Affiliation
National Cancer Institute
ORCID
Career Start Year
2000
Papers
32
H Index
20
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37129971
Single-cell landscape analysis unravels molecular programming of the human B cell compartment in chronic GVHD.
JCI Insight
2023
37129971
Single-cell landscape analysis unravels molecular programming of the human B cell compartment in chronic GVHD.
JCI Insight
2023
35114411
Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome Pathogenesis.
Transplant Cell Ther
2022
35114411
Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome Pathogenesis.
Transplant Cell Ther
2022
34875023
Long-term follow-up after lymphodepleting autologous haematopoietic cell transplantation for treatment-resistant systemic lupus erythematosus.
Rheumatology (Oxford)
2022
34875023
Long-term follow-up after lymphodepleting autologous haematopoietic cell transplantation for treatment-resistant systemic lupus erythematosus.
Rheumatology (Oxford)
2022
32976576
A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease.
Blood
2021
34335560
Significant Associations of IgG Glycan Structures With Chronic Graft-Versus-Host Disease Manifestations: Results of the Cross-Sectional NIH Cohort Study.
Front Immunol
2021
32976576
A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease.
Blood
2021
34433916
Clinical characterization and cytokine profile of fatigue in hematologic malignancy patients with chronic graft-versus-host disease.
Bone Marrow Transplant
2021
35005541
Salivary ZG16B expression loss follows exocrine gland dysfunction related to oral chronic graft-versus-host disease.
iScience
2021
35005541
Salivary ZG16B expression loss follows exocrine gland dysfunction related to oral chronic graft-versus-host disease.
iScience
2021
34433916
Clinical characterization and cytokine profile of fatigue in hematologic malignancy patients with chronic graft-versus-host disease.
Bone Marrow Transplant
2021
34335560
Significant Associations of IgG Glycan Structures With Chronic Graft-Versus-Host Disease Manifestations: Results of the Cross-Sectional NIH Cohort Study.
Front Immunol
2021
31493539
Prospective Study of a Novel, Radiation-Free, Reduced-Intensity Bone Marrow Transplantation Platform for Primary Immunodeficiency Diseases.
Biol Blood Marrow Transplant
2020
31959992
Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma.
Nat Med
2020
31903638
Clinical characteristics and cytokine biomarkers in patients with chronic graft-vs-host disease persisting seven or more years after diagnosis.
Am J Hematol
2020
31493539
Prospective Study of a Novel, Radiation-Free, Reduced-Intensity Bone Marrow Transplantation Platform for Primary Immunodeficiency Diseases.
Biol Blood Marrow Transplant
2020
31903638
Clinical characteristics and cytokine biomarkers in patients with chronic graft-vs-host disease persisting seven or more years after diagnosis.
Am J Hematol
2020
31959992
Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma.
Nat Med
2020
30470981
Successful Bone Marrow Transplantation for XMEN: Hemorrhagic Risk Uncovered.
J Clin Immunol
2019
30470981
Successful Bone Marrow Transplantation for XMEN: Hemorrhagic Risk Uncovered.
J Clin Immunol
2019
29812997
T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma.
J Clin Oncol
2018
29812997
T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma.
J Clin Oncol
2018
27796910
Role of HLA-DP in the Presentation of Epitopes from the Truncated Bacterial PE38 Immunotoxin.
AAPS J
2017
28851699
An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD.
Blood
2017
28756593
Serial changes in lymphocyte subsets in patients with newly diagnosed high grade astrocytomas treated with standard radiation and temozolomide.
J Neurooncol
2017
27796910
Role of HLA-DP in the Presentation of Epitopes from the Truncated Bacterial PE38 Immunotoxin.
AAPS J
2017
28756593
Serial changes in lymphocyte subsets in patients with newly diagnosed high grade astrocytomas treated with standard radiation and temozolomide.
J Neurooncol
2017
28851699
An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD.
Blood
2017
26811520
Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease.
J Clin Oncol
2016
26811520
Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease.
J Clin Oncol
2016
27412889
T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma.
Blood
2016
27694491
Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease.
J Immunol
2016
27694491
Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease.
J Immunol
2016
27412889
T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma.
Blood
2016
25532725
Bone marrow-derived mesenchymal stromal cells harness purinergenic signaling to tolerize human Th1 cells in vivo.
Stem Cells
2015
25532725
Bone marrow-derived mesenchymal stromal cells harness purinergenic signaling to tolerize human Th1 cells in vivo.
Stem Cells
2015
25771402
Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease.
Biol Blood Marrow Transplant
2015
25771402
Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease.
Biol Blood Marrow Transplant
2015
24577531
Comparative analysis of FoxP3(+) regulatory T cells in the target tissues and blood in chronic graft versus host disease.
Leukemia
2014
24577531
Comparative analysis of FoxP3(+) regulatory T cells in the target tissues and blood in chronic graft versus host disease.
Leukemia
2014
23344265
B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma.
Clin Cancer Res
2013
24055823
Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation.
Blood
2013
23344265
B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma.
Clin Cancer Res
2013
24055823
Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation.
Blood
2013
22289893
Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation.
Blood
2012
22289893
Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation.
Blood
2012
18311596
Cholesterol is obligatory for polarization and chemotaxis but not for endocytosis and associated signaling from chemoattractant receptors in human neutrophils.
J Biomed Sci
2008
18500349
Identification of calcium-modulating cyclophilin ligand as a human host restriction to HIV-1 release overcome by Vpu.
Nat Med
2008
1 - 50 of 64
Column Actions
Search
Recommended Authors
Jianying Zhang
City of Hope National Medical Center
Career Start Year
2009
Number of shared co-authors
0
Anthony D Pomicter
Huntsman Cancer Institute, University of Utah
Career Start Year
2009
Number of shared co-authors
0
Ian M Kaplan
Adaptive Biotechnologies Corp
Career Start Year
2005
Number of shared co-authors
2
Marcin Moniuszko
Medical University of Bialystok
Career Start Year
2001
Number of shared co-authors
0
Ning Jiang
The University of Texas at Austin
Career Start Year
2000
Number of shared co-authors
1
Dorian LaTocha
Knight Cancer Institute, Oregon Health & Science University
Career Start Year
2000
Number of shared co-authors
0
Vineet Gupta
Purdue University
Career Start Year
1999
Number of shared co-authors
0
Peter T Sage
Transplant Research Center, Brigham and Women's Hospital, Harvard Medical School
Career Start Year
1998
Number of shared co-authors
1
Sunil K Joshi
Knight Cancer Institute, Oregon Health & Science University
Career Start Year
1998
Number of shared co-authors
0
Seunghee Kim-Schulze
Icahn School of Medicine at Mount Sinai
Career Start Year
1996
Number of shared co-authors
2
Manish J Butte
University of California Los Angeles
Career Start Year
1994
Number of shared co-authors
2
Volker Eckstein
Heidelberg University
Career Start Year
1990
Number of shared co-authors
0
Jose A Cancelas
Cincinnati Children's Hospital Medical Center
Career Start Year
1990
Number of shared co-authors
2
Jason G Cyster
University of California san francisco
Career Start Year
1990
Number of shared co-authors
1
Rosalba Salcedo
Center for Cancer Research, National Cancer Institute
Career Start Year
1990
Number of shared co-authors
0
Kaoru Saijo
Helen Wills Neuroscience Institute, University of California berkeley
Career Start Year
1988
Number of shared co-authors
0
Chia-Lin Tsou
Gladstone Institutes
Career Start Year
1987
Number of shared co-authors
0
Hamid Band
University of Nebraska Medical Center
Career Start Year
1985
Number of shared co-authors
0
Garry P Nolan
Stanford University School of Medicine
Career Start Year
1985
Number of shared co-authors
0
Yoko Kosaka
Oregon Health & Science University
Career Start Year
1984
Number of shared co-authors
0
Toshio Kitamura
The University of Tokyo.
Career Start Year
1984
Number of shared co-authors
0
Phuong Nguyen
Hoag Memorial Hospital Presbyterian
Career Start Year
1983
Number of shared co-authors
1
Simon C Watkins
Center for Molecular Imaging, University of Pittsburgh School of Medicine
Career Start Year
1981
Number of shared co-authors
1
Robert E Lewis
University of Nebraska Medical Center
Career Start Year
1980
Number of shared co-authors
0
Brian Seed
Center for Computational and Integrative Biology, Massachusetts General Hospital
Career Start Year
1980
Number of shared co-authors
0
Wolfgang Holter
St. Anna Children's Hospital, Medical University of Vienna
Career Start Year
1980
Number of shared co-authors
0
Peter S Linsley
8Benaroya Research Institute
Career Start Year
1978
Number of shared co-authors
1
Daniel W McVicar
National Cancer Institute
Career Start Year
1976
Number of shared co-authors
3
Ira Mellman
Genentech Inc.
Career Start Year
1974
Number of shared co-authors
2
Shigeo Koyasu
RIKEN Center for Integrative Medical Sciences (IMS)
Career Start Year
1966
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Frances T Hakim
National Cancer Institute
Co-authored papers
20
Steven Z Pavletic
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers
15
Ronald E Gress
National Cancer Institute, National Institutes of Health
Co-authored papers
14
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Co-authored papers
7
Edward W Cowen
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Co-authored papers
6
Daniel H Fowler
National Cancer Institute, National Institutes of Health
Co-authored papers
6
David F Stroncek
Center for Cellular Engineering, NIH Clinical Center, National Institutes of Health
Co-authored papers
5
Jacqueline W Mays
National Institute of Dental and Craniofacial Research, National Institutes of Health
Co-authored papers
4
Kristin Baird
National Cancer Institute, National Institutes of Health
Co-authored papers
4
David C Halverson
National Cancer Institute, National Institutes of Health
Co-authored papers
3
Xiao-Yi Yan
Liaoning Normal University
Co-authored papers
3
Susan Dhamala
National Institute of Dental and Craniofacial Research
Co-authored papers
3
Sarfraz Memon
Center for Cancer Research, National Cancer Institute.
Co-authored papers
3
William G Telford
National Cancer Institute, National Institutes of Health
Co-authored papers
3
Maryalice Stetler-Stevenson
National Cancer Institute, National Institutes of Health
Co-authored papers
3
Steven A Rosenberg
University of Colorado School of Medicine
Co-authored papers
3
Stefania Pittaluga
National Cancer Institute, National Institutes of Health
Co-authored papers
2
Kouros Owzar
Duke University
Co-authored papers
2
Veena Kapoor
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers
2
Liang Cao
National Cancer Institute, National Institutes of Health
Co-authored papers
2
Matin M Imanguli
Rutgers Robert Wood Johnson Medical School
Co-authored papers
2
John D Dickinson
University of Nebraska Medical Center (UNMC)
Co-authored papers
1
David A Rizzieri
Duke University Medical Center
Co-authored papers
1
Benjamin G Vincent
UNC School of Medicine, The University of North Carolina at Chapel Hill
Co-authored papers
1
Najibah Rehman
Cincinnati Children's Hospital Medical Center
Co-authored papers
1
Sean Davis
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers
1
Jonathan S Serody
The University of North Carolina School of Medicine
Co-authored papers
1
Alexandra F Freeman
National Institute of Allergy and Infectious Diseases
Co-authored papers
1
Susan R Davis
Co-authored papers
1
Sawa Ito
University of Pittsburgh
Co-authored papers
1
1 - 30